Dr. Anjali Kapoor

Hi, everyone.

Welcome to Backstable Urology.

I'm your host today, Dr. Anjali Kapoor.

I'm a urogynecologist and reconstructive pelvic surgeon in central New Jersey with Hackensack Meridian Health.

And today I'm joined by a mentor, a colleague, and a friend, Dr. Jason Kim.

He is a professor of urology at the Renaissance School of Medicine at Stony Brook University, where he specializes in urogynecology and reconstructive pelvic surgery.

He completed his residency training at Stony Brook University and fellowship training at Virginia Mason Medical Center.

Dr. Kim serves as Director of the Women's Pelvic Health and Continence Center at Stony Brook and as the Fellowship Program Director of the Earps Fellowship at Stony Brook.

He's actively involved in national education efforts and he serves on the Executive Board of SUFU and as Chair of the Resident Education Committee.

His clinical and research interests include overactive bladder, neuromodulation, pelvic organ prolapse, stress incontinence, and innovations in urodynamics.

He is passionate about advancing evidence-based care while improving the patient experience in functional urology.

And so today we're diving deep into the topic of overactive bladder in women.

This is an important topic within both general urology and urogynecology, and the guidelines and options for management have evolved significantly in the past few years.

So Jason, if you could start us off, how do you define overactive bladder in your practice?

And so with that, I just want to say today we're mainly talking about overactive bladder in women, not necessarily overactive bladder related to BPH in men and not neurogenic lower urinary tract dysfunction.

I want to kind of segue into creating the foundation with the newer guidelines that were released in 2024 on the diagnosis and management of idiopathic overactive bladder in women.

Maybe you could start us off with just some of the major differences in the guidelines with the update that we now follow.

Do you feel like patients would go for minimally invasive therapies off of a telemedicine visit when they're first just being diagnosed with overactive bladder?

Or are those the patients that kind of start with medications and also need more of a workup in the clinic with an exam before you offer that?

Yeah.